Bioprinting: From Research to Clinical and Industrial Translation

Bioprinting: From Research to Clinical and Industrial Translation

Bioprinting is emerging as a key enabling technology in regenerative medicine and personalized healthcare. This session provides an overview of the latest processes, methods, and technological advances in 3D bioprinting, with a strong link between research, clinical application, and industrial implementation.

A particular focus lies on how bioprinting can help address the growing shortage of donor organs by enabling patient‑specific tissues, implants, and regenerative solutions, reducing dependence on transplantation and long‑term immunosuppression.

Key Topics:

• Bioprinting of living cells for regenerative medicine
• Patient‑specific implants and tissue repair
• Translation from lab to clinic and industry
• International research and industrial collaboration
• The role of the Netherlands in the European bioprinting ecosystem
• Alignment with Horizon Europe Cluster Health and future funding opportunities

Program:

• 14:00 – 14:05 – Introduction, welcome and outline of the program
• 14:05-14:25 – Bone marrow engineering & mimicking – Cornelia Lee-Thedieck
• 14:25-14:45 – 3D Bioprinting: from the lab to translational applications – Monize Caiado Decarli
• 14:45-15:05 – 3D Bioprinting the Heart: From Engineered Tissues to Regenerative Therapies – Joost Sluijter
• 15:05-15:10: Bridge to pitches: Short introduction to the pitch format
• 15:10-15:15: Pitch 1: Bioprinting & AI – Riccardo Levato
• 15:15-15:20: Pitch 2: An integral approach to replace animal-derived products in cell culture – Melissa van Velthoven
• 15:20-15:30: Pitch 3:Bridging Innovation and Healthcare – Joost van Duijn

Medeorganisatoren: Jutta Wirth, Wageningen University & Research; Edwin Roovers, High Tech NL Life Sciences en Zerafet Tenwolde, Z3Dlabs.